Literature DB >> 21697333

Group B streptococci causing neonatal infections in barcelona are a stable clonal population: 18-year surveillance.

E R Martins1, A Andreu, P Correia, T Juncosa, J Bosch, M Ramirez, J Melo-Cristino.   

Abstract

We analyzed 212 group B streptococci (GBS) from newborns with invasive infections in the area of Barcelona, Spain, between 1992 and 2009, with the aim of documenting changes in the prevalences of serotypes, antimicrobial resistance, and genetic lineages and evaluating their associations with either early-onset disease (EOD) or late-onset disease (LOD). Serotypes III (n = 118) and Ia (n = 47) together accounted for nearly 78% of the isolates. All isolates carried an alpha or alpha-like protein gene, and specific associations between genes and serotypes, such as serotype Ib and bca, serotype II and bca, serotype III and rib, and serotype V and alp3, reflected the presence of particular genetic lineages. Macrolide resistance (14.2%) was significantly associated with serotype V. Pulsed-field gel electrophoresis (PFGE) clustering was an excellent predictor of serotype and antibiotic resistance. The combination of PFGE and multilocus sequence typing revealed a large number of genetically distinct lineages. Still, specific lineages were dominant in our collection, particularly the serotype III/ST17/rib lineage, which had enhanced potential to cause LOD. Serotype Ia was concentrated in a single PFGE cluster composed of two genetic lineages: ST23/eps and ST24/bca. The ST24/bca sublineage of serotype Ia, which is found infrequently elsewhere, may be emerging as an important cause of neonatal invasive infections in the Mediterranean region. In spite of the introduction of prophylaxis, resulting in a pronounced decline in the frequency of EOD, the study revealed a remarkably stable clonal structure of GBS causing neonatal infections in Barcelona over a period of 18 years.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21697333      PMCID: PMC3147731          DOI: 10.1128/JCM.00271-11

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  48 in total

1.  Phylogenetic lineages of invasive and colonizing strains of serotype III group B Streptococci from neonates: a multicenter prospective study.

Authors:  Feng-Ying C Lin; April Whiting; Elisabeth Adderson; Shinji Takahashi; Diane Marie Dunn; Robert Weiss; Parvin H Azimi; Joseph B Philips; Leonard E Weisman; Joan Regan; Penny Clark; George G Rhoads; Carl E Frasch; James Troendle; Patricia Moyer; John F Bohnsack
Journal:  J Clin Microbiol       Date:  2006-04       Impact factor: 5.948

2.  Population structure of invasive and colonizing strains of Streptococcus agalactiae from neonates of six U.S. Academic Centers from 1995 to 1999.

Authors:  John F Bohnsack; April Whiting; Marcelo Gottschalk; Diane Marie Dunn; Robert Weiss; Parvin H Azimi; Joseph B Philips; Leonard E Weisman; George G Rhoads; Feng-Ying C Lin
Journal:  J Clin Microbiol       Date:  2008-02-20       Impact factor: 5.948

3.  Illustration of a common framework for relating multiple typing methods by application to macrolide-resistant Streptococcus pyogenes.

Authors:  J A Carriço; C Silva-Costa; J Melo-Cristino; F R Pinto; H de Lencastre; J S Almeida; M Ramirez
Journal:  J Clin Microbiol       Date:  2006-07       Impact factor: 5.948

4.  Early-onset and late-onset neonatal group B streptococcal disease--United States, 1996-2004.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2005-12-02       Impact factor: 17.586

5.  Distribution of novel and previously investigated virulence genes in colonizing and invasive isolates of Streptococcus agalactiae.

Authors:  T C Smith; S A Roehl; P Pillai; S Li; C F Marrs; B Foxman
Journal:  Epidemiol Infect       Date:  2006-12-07       Impact factor: 2.451

Review 6.  Group B Streptococcus: global incidence and vaccine development.

Authors:  Atul Kumar Johri; Lawrence C Paoletti; Philippe Glaser; Meenakshi Dua; Puja Kumari Sharma; Guido Grandi; Rino Rappuoli
Journal:  Nat Rev Microbiol       Date:  2006-11-06       Impact factor: 60.633

7.  First molecular characterization of group B streptococci with reduced penicillin susceptibility.

Authors:  Kouji Kimura; Satowa Suzuki; Jun-ichi Wachino; Hiroshi Kurokawa; Kunikazu Yamane; Naohiro Shibata; Noriyuki Nagano; Haru Kato; Keigo Shibayama; Yoshichika Arakawa
Journal:  Antimicrob Agents Chemother       Date:  2008-05-19       Impact factor: 5.191

8.  Analysis of group B streptococcal isolates from infants and pregnant women in Portugal revealing two lineages with enhanced invasiveness.

Authors:  E R Martins; M A Pessanha; M Ramirez; J Melo-Cristino
Journal:  J Clin Microbiol       Date:  2007-08-15       Impact factor: 5.948

9.  Molecular epidemiology and distribution of serotypes, surface proteins, and antibiotic resistance among group B streptococci in Italy.

Authors:  Giovanni Gherardi; Monica Imperi; Lucilla Baldassarri; Marco Pataracchia; Giovanna Alfarone; Simona Recchia; Graziella Orefici; Giordano Dicuonzo; Roberta Creti
Journal:  J Clin Microbiol       Date:  2007-07-18       Impact factor: 5.948

10.  The frequency of genes encoding three putative group B streptococcal virulence factors among invasive and colonizing isolates.

Authors:  Shannon D Manning; Moran Ki; Carl F Marrs; Kiersten J Kugeler; Stephanie M Borchardt; Carol J Baker; Betsy Foxman
Journal:  BMC Infect Dis       Date:  2006-07-17       Impact factor: 3.090

View more
  21 in total

1.  High prevalence of fluoroquinolone-resistant group B streptococci among clinical isolates in China and predominance of sequence type 19 with serotype III.

Authors:  Hui Wang; Chunjiang Zhao; Wenqiang He; Feifei Zhang; Liyan Zhang; Bin Cao; Ziyong Sun; Yingchun Xu; Qing Yang; Yaning Mei; Bijie Hu; Yunzhuo Chu; Kang Liao; Yunsong Yu; Zhidong Hu; Yuxing Ni
Journal:  Antimicrob Agents Chemother       Date:  2013-01-07       Impact factor: 5.191

2.  Dominance of serotype Ia among group B Streptococci causing invasive infections in nonpregnant adults in Portugal.

Authors:  E R Martins; J Melo-Cristino; M Ramirez
Journal:  J Clin Microbiol       Date:  2012-01-04       Impact factor: 5.948

3.  Molecular epidemiology of group B streptococci in Ireland reveals a diverse population with evidence of capsular switching.

Authors:  Mary Meehan; Robert Cunney; Mary Cafferkey
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-01-28       Impact factor: 3.267

4.  Molecular epidemiology and distribution of serotypes, genotypes, and antibiotic resistance genes of Streptococcus agalactiae clinical isolates from Guelma, Algeria and Marseille, France.

Authors:  A Bergal; L Loucif; D E Benouareth; A A Bentorki; C Abat; J-M Rolain
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-09-28       Impact factor: 3.267

5.  Distribution of pilus islands in Streptococcus agalactiae that cause human infections: insights into evolution and implication for vaccine development.

Authors:  E R Martins; A Andreu; J Melo-Cristino; M Ramirez
Journal:  Clin Vaccine Immunol       Date:  2012-12-26

6.  Associations between capsular serotype, multilocus sequence type, and macrolide resistance in Streptococcus agalactiae isolates from Japanese infants with invasive infections.

Authors:  M Morozumi; T Wajima; Y Kuwata; N Chiba; K Sunaoshi; K Sugita; H Sakata; S Iwata; K Ubukata
Journal:  Epidemiol Infect       Date:  2013-07-18       Impact factor: 4.434

7.  Association between capsular serotype V and macrolide resistance in group B Streptococcus.

Authors:  P Sendi; S Fröhlicher
Journal:  Epidemiol Infect       Date:  2014-06-05       Impact factor: 4.434

8.  Serotype IV and invasive group B Streptococcus disease in neonates, Minnesota, USA, 2000-2010.

Authors:  Patricia Ferrieri; Ruth Lynfield; Roberta Creti; Aurea E Flores
Journal:  Emerg Infect Dis       Date:  2013-04       Impact factor: 6.883

9.  Antibiotic resistance of Streptococcus agalactiae isolated from pregnant women in Garankuwa, South Africa.

Authors:  John Y Bolukaoto; Charles M Monyama; Martina O Chukwu; Sebotse M Lekala; Maphoshane Nchabeleng; Motlatji R B Maloba; Rooyen T Mavenyengwa; Sogolo L Lebelo; Sam T Monokoane; Charles Tshepuwane; Sylvester R Moyo
Journal:  BMC Res Notes       Date:  2015-08-20

10.  Streptococcus agalactiae in Brazil: serotype distribution, virulence determinants and antimicrobial susceptibility.

Authors:  Vanusa G Dutra; Valéria M N Alves; André N Olendzki; Cicero A G Dias; Alessandra F A de Bastos; Gianni O Santos; Efigênia L T de Amorin; Meireille  B Sousa; Rosemary Santos; Patricia C S Ribeiro; Cleuber F Fontes; Marco Andrey; Kedma Magalhães; Ana A Araujo; Lilian F Paffadore; Camila Marconi; Eddie F C Murta; Paulo C Fernandes; Maria S G Raddi; Penélope S Marinho; Rita B G Bornia; Jussara K Palmeiro; Libera M Dalla-Costa; Tatiana C A Pinto; Ana Caroline N Botelho; Lúcia M Teixeira; Sérgio Eduardo L Fracalanzza
Journal:  BMC Infect Dis       Date:  2014-06-12       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.